A National Commercialisation Arm Asia Agency for Science, Technology & Research

Oxford Oracle benchmarked a overall performance in research in Asia, innovation and enterprise against nine other innovating economies, and then conducted in-depth research to fully understand the biomedical science programmes performance. During 2015, Oxford Oracle worked with a national commercialisation arm on an ambitious assignment to analyse the effectiveness of ETPLs Biomedical Sciences Gap-Funding Programme. The project enabled a national commercialisation arm to understand how this translational fund was performing as compared to similar funds worldwide in the field of biomedical sciences (BMS). This critical review saw Oxford Oracle conduct in-depth research to fully understand the programmes performance. A national commercialisation arm has been able to use Oxford Oracle's advice to develop a strategy for improving the commercialisation of a BMS research in Asia, and ultimately contribute to its economic growth. Oxford Oracles work involved two principal tasks: 1. Benchmarking and analysis of a performance in research in Asia, innovation and enterprise 2. Review of the Biomedical Sciences Gap-Funding Programme

• A national commercialisation arm asked Oxford Oracle to examine a research in Asia, innovation and enterprise environment, overall and as it relates to the BMS sector, to allow its performance to be benchmarked against other innovating economies (including the UK, the US, Europe, and leading Asian innovation economies). Oxford Oracle used a range of sources and publications, including OECD data on national and government expenditure on R&D, and reported the results of its analysis to a national commercialisation arm.
• Research: To review ETPLs translational fund, Oxford Oracle conducted its own primary research using questionnaires and face-to-face interviews with researchers, a national commercialisation arm commercialisation officers, a national commercialisation arm senior management and selected end-users of gap-funded technology. ETPLs processes, covering a range of activities such as project management and engagement, were also compared with those of other gap funds.
• Data analysis and interpretation: Oxford Oracle analysed the collected data and used it to identify the strengths and weaknesses of ETPLs approach to commercialisation of BMS innovations. Oxford Oracle used its research findings to make a series of recommendations to a national commercialisation arm for increasing the fund's success, including: sharpening the funds research objectives; enhancing communication with target groups; developing the fund approval process; and introducing revised key performance indicators to encourage activity. Oxford Oracle's expert insight has enabled a national commercialisation arm to implement specific, validated actions for increasing the commercial adoption of innovations from a BMS research institutions in Asia, building on the undoubted success of its current BMS programme and continuing to place Asia at the forefront of worldwide innovation and research exploitation.